Company Quick10K Filing
CNL Healthcare Properties II
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-09
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-03-20
10-Q 2018-09-30 Filed 2018-11-08
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-15
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-11
10-K 2016-12-31 Filed 2017-02-15
10-Q 2016-09-30 Filed 2016-11-10
10-Q 2016-06-30 Filed 2016-08-10
10-Q 2016-03-31 Filed 2016-05-06
8-K 2020-03-19
8-K 2020-02-28
8-K 2020-01-24
8-K 2019-11-01
8-K 2019-09-10
8-K 2019-05-06
8-K 2019-03-13
8-K 2019-03-01
8-K 2019-01-24
8-K 2018-10-31
8-K 2018-09-28
8-K 2018-08-31
8-K 2018-07-03
8-K 2018-06-12
8-K 2018-03-14
8-K 2018-03-06
8-K 2018-01-30
8-K 2017-12-31
8-K 2017-12-27

CNL Healthcare Properties II Financials

CHPII Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash2002003,1405,9776,6069,47015,58612,42218,93423,1559,9648,2387,9084,7984,981
Accounts Receivable
Inventory
PP&E20,69620,56120,40731,08630,82730,58153,94253,57342,60742,225
Assets2002003,6096,40928,65631,44137,24148,35454,41958,31669,74767,28966,21748,323
Accounts Payable
Long-Term Debt16,36216,36216,36219,81219,55519,57524,81224,50018,6806,150
Liabilities0076457616,89617,12817,53621,84422,13022,04927,90425,62425,8136,977
Stockholders' Equity2002002,8455,83311,76114,31319,70426,51032,28936,26741,84341,66540,40441,34640,877
Income Statement ($'000)2016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue111,0711,0961,1301,5331,5621,9072,4352,1982,1521,491
Cost of Revenue11010874
Gross Profit2,0892,0441,416
R&D
SG&A93217235251179253320286301403422372
Tax3012563114-103100
Net Income-111-232-251-392-308-366-390-350-459-606-556943-469
Cash Flow ($'000)2016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-166-15433203-38157290426232209
Cash Investing-21,770-95-54-13,915-11-24,773-5115,009-27
Cash Financing3,00422,2002,9525,91210,7886,36611,292-705-18,3500